01 5Ajinomoto Health & Nutrition North America Inc.
02 1KYOWA HAKKO BIO CO., LTD.
03 1Professional Compounding Centers of America
04 1Shanghai Kyowa Amino Acid Co., Ltd
05 1Spectrum Laboratory Products, Inc.
01 2Histidine
02 1L-HISTIDINE
03 3L-Histidine
04 1L-Histidine Hydrochloride
05 1L-Histidine Monohydrochloride Monohydrate
06 1Mix MP-9J
01 7Japan
02 1U.S.A
03 1United Kingdom
HISTIDINE MONOHYDROCHLORIDE MONOHYDRATE
NDC Package Code : 51495-817
Start Marketing Date : 2008-01-04
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 51495-716
Start Marketing Date : 2022-10-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 51495-916
Start Marketing Date : 2022-10-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 51495-816
Start Marketing Date : 2022-10-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
HISTIDINE; ISOLEUCINE; LYSINE HYDROCHLORIDE; METHIONINE; PHENYLALANINE; THREONINE; TRYPTOPHAN; VALINE
NDC Package Code : 51495-381
Start Marketing Date : 2022-09-09
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1.26kg/100kg 10.64kg/100kg 17.13kg/100kg 3.27kg/100kg 6.73kg/100kg 9.27kg/100kg .7kg/100kg 11kg/100kg)
Marketing Category : DRUG FOR FURTHER PROCESSING
NDC Package Code : 12497-1032
Start Marketing Date : 1978-03-15
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (50kg/50kg)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
NDC Package Code : 51927-0308
Start Marketing Date : 2023-08-03
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
NDC Package Code : 74920-004
Start Marketing Date : 2020-03-09
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (25kg/25kg)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
HISTIDINE MONOHYDROCHLORIDE MONOHYDRATE
NDC Package Code : 49452-3507
Start Marketing Date : 2020-08-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
A L-Histidine manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of L-Histidine, including repackagers and relabelers. The FDA regulates L-Histidine manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. L-Histidine API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of L-Histidine manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A L-Histidine supplier is an individual or a company that provides L-Histidine active pharmaceutical ingredient (API) or L-Histidine finished formulations upon request. The L-Histidine suppliers may include L-Histidine API manufacturers, exporters, distributors and traders.
click here to find a list of L-Histidine suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing L-Histidine as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for L-Histidine API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture L-Histidine as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain L-Histidine and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a L-Histidine NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of L-Histidine suppliers with NDC on PharmaCompass.
We have 5 companies offering L-Histidine
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?
